oninvasive diagnostics of basal cell carcinoma in the head and neck by dermoscopy and handheld reflectance confocal microscopy.

etherlands Cancer Institute0 个研究点目标入组 258 人开始时间: 待定最近更新: 2024年3月25日

试验速览

暂无简介。

•1. Patients with suspected primary BCC on naked-eye examination as assessed by an experienced board-certified dermatologist.
•2. Lesion localization in the head and neck (i.e. supraclavicular/above the 7th cervical vertebrae) with an indication for surgical treatment.
•3. Anatomic localization of the lesion allows evaluation by HH-RCM and dermoscopy.
•4. Patient age ¡Ý 18 years and is willing and able to comply with the study requirements and give written informed consent

•1. Recurrent BCC, defined as a suspected BCC localized within 5mm from the site of previously surgically or non-surgically treated BCC.
•2. Suspected BCC localized outside the head and neck (i.e. infraclavicular/below the 7th cervical vertebrae).
•3. Anatomical localization of lesion not accessible by HH-RCM or dermoscopic imaging.
•4. Patients with genetic syndromes with increased risk of developing BCCs (e.g. Gorlin-Goltz, xeroderma pigmentosa).
•5. Patients being treated by immunosuppressive medication.
•6. Lesions on previously radiated skin.
•7. Patients not eligible for surgical excision due to co-morbidity/ patient refusal.

发起方

etherlands Cancer Institute